RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Amarillo, TX · Austin, TX · +137 more sites
1 recruiting obesity studies with a site in Lewisville, TX.
Sponsor: Amgen
Amarillo, TX · Austin, TX · +137 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.